Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019829 (
Hodgkin's disease
)
30,247
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The expression of
vimentin
in Reed-Sternberg cells in 61 samples of
Hodgkin's disease
(HD) was examined using an avidin-biotin-peroxidase complex technique. Forty biopsies (66%) expressed
vimentin
, and expression was seen in all subtypes of HD. No immunophenotypic differences between
vimentin
-positive and
vimentin
-negative cases were noted. The significance of such expression is unclear, but may be related to the alterations in growth and differentiation that are typical of neoplastic cells.
...
PMID:Vimentin expression by Reed-Sternberg cells in Hodgkin's disease. 163 52
Immunocytochemistry with the use of monoclonal antibodies to
vimentin
, keratin, desmin, neurofilaments and leukocyte common antigen (LCA) was applied to 53 fine needle aspirates of small cell-, round-, blue-cell malignant tumors of childhood (neuroblastomas, nephroblastomas, non-
Hodgkin
's lymphomas, Ewing's sarcomas and rhabdomyosarcomas). The results revealed the following immunophenotypes: neuroblastomas were positive for neurofilaments. Nephroblastomas contained
vimentin
(in blastema cells), keratin (in epithelial and blastema cells) Non-
Hodgkin
's lymphomas were
vimentin
and LCA positive, keratin negative. Ewing's sarcomas displayed multidirectional differentiation. Rhabdomyosarcomas were desmin and
vimentin
positive. It is concluded that immunocytochemistry in fine needle aspirates should be used as an objective evidence to support morphologic differential diagnosis of small cell-, round-, blue cell malignant tumors of childhood.
...
PMID:Immunocytochemistry in fine needle aspirates of small cell-, round-, blue-cell malignant tumors of childhood (neuroblastoma, nephroblastoma, lymphoma, Ewing's sarcoma, rhabdomyosarcoma). 166 3
An immunohistochemical study of 63 cases of
Hodgkin's disease
was undertaken using formalin-fixed paraffin embedded tissue sections. The antibodies used were against L26, LN-1, LN-2, EMA (epithelial membrane antigen), Leu-M1, Vimentin, UCHL-1, S-100, and lysozyme.
Hodgkin's disease
could be divided into three groups: the first group was LN-1+/L26+/
vimentin
-, the second LN-1-/L26+/vimentin+, and the third LN-1-/L26-/vimentin+). Sixteen cases of follicular lymphomas were also examined and were all positive for LN-1 and L26 and negative for
vimentin
. Thus the
vimentin
negativity of the first group, including 7 nodular lymphocyte-predominant cases, gives further evidence of their germinal center B-cell origin. Since
vimentin
is expressed mainly in the immature stage of B-lymphocytes, the second group of
Hodgkin's disease
may represent immature B-cell
Hodgkin's disease
. In the third group,
vimentin
was present in Reed-Sternberg's (RS) and
Hodgkin
's (H) cells in 45 of the 48 cases (92.5%). In none of 48 cases were these cells positive for S-100 or lysozyme, but strong
vimentin
-positivity still suggested monocytic or histiocytic origin. The results of our study suggest, at least, divergent origin of RS's and H's cells.
...
PMID:Reciprocal/dichotomic expression of vimentin and B cell differentiation antigens in Reed-Sternberg's cells. 168 87
There are few data on the reactivity of Reed-Sternberg (RS) cells with antibodies against
vimentin
. In a preliminary survey of biopsy specimens from 16 cases of
Hodgkin's disease
(HD), we found that the antivimentin (V9) monoclonal antibody stained RS cells in 6 cases. We therefore examined
vimentin
expression on RS cells immunohistologically in 38 Bouin-fixed and paraffin-embedded lymph nodes with HD [lymphocyte predominance (LP) 4; nodular sclerosis (NS) 23; mixed cellularity (MC) 7; lymphocyte depletion (LD) 4]. The results were correlated with the histopathological features, the immunohistological phenotype of the RS cells, and the findings obtained from molecular genetics studies (available in 13 cases). RS cells were found to express strong and diffuse cytoplasmic staining for
vimentin
in 13 cases, all of the NS subtype. No differences in antigenic expression on RS cells were found between the
vimentin
-positive and negative cases within the NS subtype. DNA analysis revealed no B- or T-cell clonal populations in the tested samples. The results indicated that RS cells were immunostained by anti-
vimentin
(V9) antibody with a relatively high frequency, but only in the NS subtype of HD. This subtype, however, was heterogeneous according to
vimentin
immunostaining on RS cells. The significance of this finding concerning the RS cell origin in this subset is discussed.
...
PMID:Anti-vimentin antibody reactivity with Reed-Sternberg cells of Hodgkin's disease. 169 31
Human non-
Hodgkin
's lymphomas were studied by means of an avidin-biotin complex immunoperoxidase method using several monoclonal antibodies against the intermediate filament protein,
vimentin
. The study cases were 61 B-cell lymphomas (including 2 plasmacytomas) and 30 T-cell lymphomas (including 8 cases of mycosis fungoides). Twelve of the 61 B-cell lymphomas were positive for
vimentin
, and were composed of extrafollicular-center cells such as immunoblastic and plasmacytoid cells. On the other hand, lymphomas of follicular center cell origin were negative for
vimentin
. All cases of T-cell lymphoma except for 14 (all of 9 AILD-type lymphomas, all of 4 lymphoblastic lymphomas and one diffuse mixed small/large lymphoma) were positive for
vimentin
. Although
vimentin
expression appeared to be influenced by various conditions such as the proportion of T- and B-cell subsets, or B-cell proliferation rate, follicular center cells were constantly negative for
vimentin
.
...
PMID:Study of vimentin expression in non-Hodgkin's lymphoma using paraffin sections. 169 93
Double and triple immunocytochemical detection methods for routine use in histopathology were investigated. For double immunostaining, the combinations of immunogold-silver staining (IGSS, black) with an immunoperoxidase method (3-amino-9-ethylcarbazole, red-brown) or with an immunoalkaline phosphatase method (Fast Red TR, red) proved very useful. These were followed by a Haematoxylin counterstain. An alternative approach using immunoperoxidase (red-brown) and immunoalkaline phosphatase (Fast Blue, BB, blue) methods was also successful, particularly for frozen sections of unfixed tissue and for the establishment of intermediate filament coexpression in tumours. The coexistence of desmin with
vimentin
in rhabdomyosarcoma, and of glial fibrillary acidic protein with
vimentin
in ependymoma, could be demonstrated directly by means of non-crossreacting murine and rabbit antibodies in the above combinations. The black (IGSS), red-brown (immunoperoxidase) and blue (immunoalkaline phosphatase) colours gave excellent contrast in triple immunostaining. The side-by-side demonstration of helper and suppressor T lymphocytes during renal allograft rejection, of kappa and lambda light chains in B-immunoblastic lymphoma, and of T and B lymphocyte populations in non-
Hodgkin
's lymphomas provided immediate information on the topography and cellular organization of the tissues.
...
PMID:Double and triple immunocytochemical labelling at the light microscope level in histopathology. 170 50
The immunophenotypes of 74 malignant lymphomas (9
Hodgkin's disease
, 19 low-grade B-cell, 20 high-grade B-cell, 8 T-cell, and 18 large cell anaplastic lymphomas [LCAL]) have been characterized with antibodies against leucocyte differentiation antigens, keratin, and
vimentin
. All the non-LCAL were CD45 positive and keratin negative. The LCALs had a more varied immunophenotype, with CD45 present only in 11 of 18 cases and keratin present in 5 of 18 of these rare lymphomas. The lymphoid origin of these latter cases was proven by gene rearrangement studies. All LCALs were CD30+, and, where tested,
vimentin
positive. Of four different
vimentin
monoclonal antibodies tested, V9 and MVI stained the highest number of lymphomas. Positive staining of tumor cells was seen in 61 of 71 cases. Vimentin-negative cases included Burkitt's as well as some follicular lymphomas.
...
PMID:Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. 171 Dec 89
Monoclonal antibodies to keratin,
vimentin
, leukocyte common antigen (LCA) and S-100 protein have been used in fine needle aspirates of 35 metastatic malignant melanomas, 136 carcinomas, 35 sarcomas and 82 non-
Hodgkin
's lymphomas in search for immunocytochemical criteria useful in differential diagnosis of melanoma versus carcinoma, non-Hodgkin's lymphoma and sarcoma. All melanomas expressed
vimentin
and did not express keratin. Six of 14 melanomas contained S-100 protein. All carcinomas were keratin positive. Some were also
vimentin
positive. All sarcomas expressed
vimentin
. Synovial sarcomas were also keratin positive. All NHLs were
vimentin
positive, keratin negative. All NHLs except one expressed also LCA. It is concluded that keratin,
vimentin
and LCA are useful markers in differential diagnosis of malignant melanoma versus carcinoma and non-Hodgkin's lymphoma in fine needle aspirates when used together with morphologic and clinical data. However, in differential diagnosis of malignant melanoma and sarcoma these markers are of little use.
...
PMID:Immunocytochemical criteria in the differential diagnosis of malignant melanoma versus carcinoma, lymphoma and sarcoma in fine needle aspirates. 184 82
The cytologic and immunocytochemical findings in pleural effusions from three cases of angiosarcoma are presented. In two of the cases, the primary lesion was on the scalp; in the third case, an angiosarcoma of the small intestine developed after radiotherapy for
Hodgkin's disease
. Single malignant cells and small clusters of cells were seen in cytologic preparations from two cases while only single cells were seen in preparations from one case. The malignant cells had delicate, finely vacuolated cytoplasm with distinct borders. No specific morphologic features were noted. Immunoperoxidase studies revealed binding of Ulex europaeus and reactivity for
vimentin
in all three cases and expression of Factor VIII-related protein in two of the cases but no expression of epithelial markers. The clinical history and immunoperoxidase studies are necessary to distinguish angiosarcoma from metastatic adenocarcinoma and other malignancies in effusions.
...
PMID:Cytology of angiosarcoma in effusions. 192 94
Immunoreactivity with monoclonal antibodies against the intermediate filament protein,
vimentin
, and epithelial membrane antigen (EMA) was examined in 330 cases of lymphoma (317 non-
Hodgkin
's and 13
Hodgkin
's lymphomas), 12 reactive lymph nodes and mononuclear cells of the peripheral blood using either indirect immunoperoxidase staining or the avidin-biotin immunoperoxidase complex technique. The cell origin of each tumor was established using a panel of monoclonal antibodies against lymphocyte differentiation antigens. There were 41 T-cell, 247 B-cell and 29 undetermined lymphomas, and 13 cases of
Hodgkin's disease
in the series. Vimentin was expressed in 24 T-cell lymphomas (58.5%) and 60 B-cell lymphomas (24.2%). This difference in frequency was statistically significant. Vimentin expression in follicular lymphomas was less frequent than in diffuse B-cell lymphomas. In diffuse lymphomas, small and medium cell types were more reactive with anti-
vimentin
than large cell types. Reed-Sternberg cells (R-S cells) in
Hodgkin's disease
were positive for
vimentin
in 11 cases (84.6%). The frequency of EMA reactivity in lymphomas was low, particularly in T-cell lymphomas. No positive cases were found among follicular lymphomas. In diffuse non-
Hodgkin
's lymphomas, EMA was expressed only in mixed and large cell types, but never in smaller ones. In conclusion, monoclonal antibodies against
vimentin
and EMA appear to be of limited usefulness for the diagnosis of non-
Hodgkin
's lymphomas, but anti-
vimentin
antibody may be used as an adjunct to the diagnosis of R-S cells in
Hodgkin's disease
.
...
PMID:Expression of vimentin and epithelial membrane antigen in human malignant lymphomas. 223 13
1
2
3
4
Next >>